[SRNE] QoQ Quarter Result on 31-Dec-2015 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
14-Mar-2016
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- -2,400.11%
YoY- -176.03%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
Revenue 2,243 902 988 1,337 1,103 1,173 977 73.76%
PBT 14,031 -46,113 -20,027 -25,413 33,244 -10,975 -10,616 -
Tax -195 -1,164 -1,637 1,186 35,323 -17 -178 6.25%
NP 14,373 -44,949 -18,390 -23,476 -939 -10,958 -10,438 -
Tax Rate 1.39% - - - -106.25% - - -
Total Cost -12,130 45,851 19,378 24,813 2,042 12,131 11,415 -
Ratio Analysis
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
NP Margin 640.79 -4,983.26 -1,861.34 -1,755.87 -85.13 -934.19 -1,068.37 -
Per Share
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
EPS 0.22 -0.97 -0.48 -0.62 -0.03 -0.30 -0.29 -
EPS Diluted 0.22 -0.97 -0.48 -0.62 -0.03 -0.30 -0.29 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.